Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • seqansweruser
    Junior Member
    • Jan 2016
    • 2

    Novice's intro

    Hello Everyone.

    Wanted to say hello and post a question about some learning.

    Questions.

    -->Which one to master. R or Python?

    --> Where can I find sample pipelines for NGS data-analysis?
    Currently scouring through some old pub-med articles. Any other simpler source will be much appreciated.

    Thank you everyone.
  • blancha
    Senior Member
    • May 2013
    • 367

    #2
    If you're serious about bioinformatics, you'll have to learn both unfortunately, however confusing that may be.

    The one, irreplaceable, feature of R that cannot be found in Python is the library of bioinformatics programs found in the Bioconductor repository.
    R has other features that do make it a great programming language, but many of these features have been copied by Python (e.g. pandas, ...), albeit not always very succesfully.
    For example, the static graphs that can be generated by R, with ggplot2 for example, are second to none. R was also designed by statisticians so statistical analyses are very straightforward.

    Outside of bioinformatics and pure statistics, Python has become the dominant language.
    It is a very straightforward language, and given the number of users, there are constantly new modules being added.

    I know principal investigators who have based their entire, very succesful, careers solely on their mastery of R. Should they need a program to be written in Python or any other language, they ask a student or hire an employee to do it for them. As a student or an analyst, you don't have this luxury.

    The analysis pipelines are dependent on the type of analysis you want to perform.
    For RNA-Seq, I recommend reading the Nature article on the Tuxedo protocol.


    For Exome-Seq, consult the Broad institute protocol.
    Last edited by blancha; 01-06-2016, 02:05 PM.

    Comment

    • seqansweruser
      Junior Member
      • Jan 2016
      • 2

      #3
      Thank you very much. I do want to be a real bioinformatics. I currently handle LIMs programming and clinical reporting related stuff. ( lot of java framework, Ruby on rails and Restful stuff) .

      I will start focusing on R more and eventually learn Bio-python ( I know how to program in python already, need to know bio-python much much better.)



      I will download those papers and start reading.

      Thank you again.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      212 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      78 views
      0 reactions
      Last Post SEQadmin2  
      Working...